OSRH
What one share of Osr Health holds
Surgical and Medical Instruments and Apparatus
As a global healthcare holding company, with operations in South Korea and Switzerland and an office in the United States, we intend to leverage our existing and expanding network of academic and industry leaders and investor network, including venture capital and private equity, in major healthcare markets globally to identify, lead and support the growth of our subsidiaries and subsidiary candidates based on innovative research.
Osr Health’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.06 |
|---|---|
| Profit | −$0.34 |
| Cash and investments | $0.04 |
| Debt | $0.08 |
| Book value | $3.56 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | — | −$0.00 | — | −$0.00 | — | −$0.00 |
| 2023 | — | $0.05 | — | −$0.11 | — | — |
| 2024 | $1.64 | −$4.79 | — | −$0.86 | — | −$3.87 |
| 2025 | $0.13 | −$0.80 | — | −$0.19 | — | $4.78 |